col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

SAGE Publications: Journal of Oncology Pharmacy Practice
  original article Date Title Authors   All Authors
1 [GO] 2021―Aug―23 Alectinib, COVID-19 and favipiravir Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
2 [GO] 2021―May―13 Global changes to the chemotherapy service during the covid-19 pandemic Man-Chie Chow, Pinkie Chambers, Georgina Singleton, Jignesh Patel, Silvie Cooper, Charlotte Mythen, et al. (+6)
3 [GO] 2021―May―09 Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? Murat Ayhan, Şahin Laçin, Deniz T Özyükseler, Heves Sürmeli, Akif Doğan, Merve Turan, et al. (+3)
4 [GO] 2021―Apr―24 Immune-checkpoint inhibitor toxicity during a pandemic: Overcoming patient fears to provide care. A case report Christopher T Elder, Elizabeth C Davis, Stephanie Jaipal, Charles E Wight
5 [GO] 2021―Feb―11 Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic Maria Marchese, Angela Heintzman, Mark Pasetka, Flay Charbonneau, Carlo DeAngelis, Christine Peragine
6 [GO] 2021―Jan―28 Cancer patient experience of telephone clinics implemented in light of COVID-19 Melanie Dalby, Alison Hill, Shereen Nabhani-Gebara
7 [GO] 2021―Jan―20 Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? Emre Yekedüz, Güngör Utkan, Yüksel Ürün
8 [GO] 2021―Jan―18 Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City Prakirthi Yerram, Jennifer Thackray, Lisa R Modelevsky, Josiah D Land, Samantha N Reiss, Krisoula H Spatz, et al. (+18)
9 [GO] 2020―Nov―02 Coping with the residency program during COVID-19: Hematology oncology pharmacy residents’ perspective Aeshah A AlAzmi, Fouad AlNajjar, Majed AlShomrani
10 [GO] 2020―Oct―23 Response of an oncology unit in the midst of the COVID-19 outbreak Michalis Liontos, Efstathios Kastritis, Magdalini Migkou, Konstantinos Koutsoukos, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, et al. (+4)
11 [GO] 2020―Oct―21 Tyrosine kinase inhibitors and COVID-19 Başcı Semih, Yiğenoğlu Tuğçe Nur, Dal Mehmet Sinan, Korkmaz Serdal, Turgut Burhan, Altuntaş Fevzi
12 [GO] 2020―Oct―21 Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors Banu Cakir
13 [GO] 2020―Oct―08 Optimizing the role of ambulatory chemotherapy in response to the Covid-19 pandemic Racha Sabbagh Dit Hawasli, Shereen Nabhani-Gebara
14 [GO] 2020―Sep―29 A practical approach to the management of colorectal cancer during the COVID-19 crisis in the reference cancer treatment center in Tunisia Feriel Letaief, Imen Gharbi, Adel Hamdi, Yosra Yahyaoui, Mona Ayadi, Imen Blousa, Amel Mezlini
15 [GO] 2020―Sep―25 Clinical strategies for optimizing infusion center care through a pandemic Kirollos S Hanna, Eve M Segal, Ashley Barlow, Brooke Barlow
16 [GO] 2020―Aug―28 Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors Semih Başcı, Naim Ata, Fevzi Altuntaş, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Serdal Korkmaz, et al. (+13)
17 [GO] 2020―Aug―14 Switch in use of midazolam for cancer patients during the COVID-19 pandemic Guillaume Marliot, Nicolas Penel, Vincent Gamblin
18 [GO] 2020―Aug―14 Suggestion of Tunisia’s medical oncologist in the management of breast cancer during COVID-19 pandemic Yosra Yahyaoui, Zahra Ghodhbani, Adel Hamdi, Feryel Letaief, Yosr Zenzri, Azza Ben Said, et al. (+2)
19 [GO] 2020―Jul―06 Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19? Elif Aras-Atik, Kamer Tecen-Yucel, Aygin Bayraktar-Ekincioglu
20 [GO] 2020―Jun―25 Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations Majed Alshamrani, Atika AlHarbi, Nora Alkhudair, Fouad AlNajjar, Mansoor Khan, Abdulaziz Ben Obaid, et al. (+6)
21 [GO] 2020―Jun―07 Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider? Mark A Marinella
22 [GO] 2020―May―29 Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan Satoru Mitsuboshi, Masaki Yoshino, Hiroki Hosokawa, Hirokazu Isobe, Kenichi Kobayashi
23 [GO] 2020―May―19 Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab Emre Yekedüz, Bengü Dursun, Güle Ç Aydın, Satı C Yazgan, Halis H Öztürk, Alpay Azap, et al. (+2)
24 [GO] 2020―May―15 Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety Marliese Alexander, Jennifer Jupp, Grace Chazan, Shaun O’Connor, Alexandre Chan


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.006 sec